Grand Brilliance Group Holdings Ltd is an investment holding company primarily engaged in the supply of medical devices. The Company also provides medical device solutions, including market trend analysis, medical device procurement, after-sales service, technical support and training, medical device rental services, and quality assurance. The Company primarily sells medical device products, including medical consumables, medical equipment, and medical devices. In addition, the Company also offers repair services and medical device rental services.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
14/07/26	HK$0.1320	+0.76%	30,000
13/07/26	HK$0.1310	-5.76%	330,000
10/07/26	HK$0.1390	0.00%	0
09/07/26	HK$0.1390	0.00%	20,000
08/07/26	HK$0.1390	0.00%	40,000

Delayed Quote Hong Kong S.E.

More quotes

Income Statement and Estimates

More financial data

Market Closed - Hong Kong S.E. Other stock markets 12:08:53 14/07/2026 +04			5-day change	1st Jan Change
0.1320 ^HKD	+0.76%		-5.04%	+0.76%

06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI

Market Cap	105M 13.37M 11.68M 10.8M 9.98M 18.79M 1.28B 19.13M 129M 50.54M 629M 50.22M 49.11M 2.17B	P/E 2024	10.2x	P/E 2025	9.13x
Enterprise Value	42.43M 5.41M 4.73M 4.37M 4.04M 7.61M 520M 7.75M 52.16M 20.46M 255M 20.34M 19.89M 877M	EV / Sales 2024	0.22x	EV / Sales 2025	0.25x
Free-Float	27.02%	Yield 2024	2.5%	Yield 2025	2.31%

06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
11-21	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI
21/06/25	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
20/06/25	Grand Brilliance Group Holdings Limited Announces Interim Dividend for the Financial Year End 31 March 2025, Payable on August 11, 2025	CI
27/05/25	Grand Brilliance Group Holdings Limited Announces Board and Committee Changes, Effective 1 June 2025	CI
14/03/25	Grand Brilliance Group Holdings Limited Announces Resignation of Mr. Mui Wai Sum as Independent Non-Executive Director and Chairman and Member of the Audit Committee and Member of Remuneration Committee	CI
08/11/24	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2024	CI
28/06/24	Grand Brilliance Group Holdings Limited Declares Interim Dividend for the Year Ended 31 March 2024, Payable on or Before 12 August 2024	CI
28/06/24	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
13/11/23	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI
15/09/23	Grand Brilliance Group Holdings Limited Announces Board Changes, Effective September 18, 2023	CI
11/08/23	Grand Brilliance Group Holdings Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	CI

1 day	+0.76%
1 week	-5.04%
Current month	-5.71%
1 month	-13.16%
3 months	+5.60%
6 months	+2.33%
Current year	+0.76%

Grand Brilliance Group Holdings Limited Stock

Stocks

8372

KYG4136R1020

Medical Equipment, Supplies & Distribution

Valuation: Grand Brilliance Group Holdings Limited

Chart: Grand Brilliance Group Holdings Limited

Latest news : Grand Brilliance Group Holdings Limited

Quotes and Performance

Course Extremes

Managers and Directors: Grand Brilliance Group Holdings Limited

Medical Equipment Wholesale

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	0.13	0.14
1 month	0.13	0.16
Current year	0.12	0.18
1 year	0.1	0.18
3 years	0.07	0.18
5 years	0.06	0.18
10 years	0.06	0.57

Manager	Title	Age	Since
Bik Kwan Wong CEO	Chief Executive Officer	57	01/03/2018
Chong Chi Cheung DFI	Director of Finance/CFO	48	-
Wai Man Lau SAM	Sales & Marketing	39	01/02/2015

Director	Title	Age	Since
Leung Sing Ng BRD	Director/Board Member	77	01/03/2018
Fan Wa Chiu BRD	Director/Board Member	61	01/06/2025
Bik Kwan Wong CHM	Chairman	57	01/03/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GRAND BRILLIANCE GROUP HOLDINGS LIMITED	+0.76%	-5.04%	+10.00%	+62.96%	13.37M
HENRY SCHEIN, INC.	+1.31%	+0.08%	+22.96%	+8.11%	9.77B
SHIP HEALTHCARE HOLDINGS, INC.	+0.48%	-0.07%	+12.92%	+1.35%	1.3B
SHANGHAI C&D INNOSTIC MEDICAL TECHNOLOGY GROUP CO., LTD.	+13.74%	+15.78%	-	-	1.34B
AS ONE CORPORATION	-0.14%	+3.07%	+2.33%	-12.13%	1.07B
COWEALTH MEDICAL CHINA CO.,LTD.	+2.57%	-3.58%	+53.28%	+28.71%	616M
GKHT MEDICAL TECHNOLOGY CO., LTD.	+5.60%	+3.86%	-19.36%	-58.84%	578M
NIPPON CARE SUPPLY CO., LTD.	+1.15%	+2.45%	+109.25%	+166.06%	416M
EXCELSIOR MEDICAL CO., LTD.	+0.85%	+2.30%	-10.88%	-12.75%	414M
ACCENDRA HEALTH, INC.	+7.12%	+12.11%	-54.71%	-81.15%	258M
Average	+3.34%	+2.50%	+13.98%	+11.37%	1.58B
Weighted average by Cap.	+2.48%	+1.80%	+20.24%	+6.60%

	2024	2025
Net sales	81.9M 10.45M 9.13M 8.44M 7.8M 14.69M 1B 14.95M 101M 39.5M 491M 39.25M 38.38M 1.69B	94.45M 12.05M 10.53M 9.73M 8.99M 16.94M 1.16B 17.24M 116M 45.55M 567M 45.26M 44.26M 1.95B
Net income	7.86M 1M 876K 810K 748K 1.41M 96.26M 1.43M 9.66M 3.79M 47.14M 3.76M 3.68M 162M	9.46M 1.21M 1.05M 975K 901K 1.7M 116M 1.73M 11.63M 4.56M 56.77M 4.53M 4.43M 195M
Net Debt	-61.91M -7.9M -6.9M -6.38M -5.9M -11.1M -759M -11.3M -76.1M -29.86M -372M -29.67M -29.02M -1.28B	-62.36M -7.96M -6.95M -6.43M -5.94M -11.18M -764M -11.39M -76.66M -30.08M -374M -29.89M -29.23M -1.29B